Patents/Assignees

Abbvie Inc.

60 patents in portfolio

US12570664utility2026
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
0 cites
US12502420utility2025
Clostridium Botulinum Serotype a Neurotoxin (bont/a) Sequence Variants
0 cites
US12365689utility2025
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
0 cites
USD1082224design2025
Carrying Vest
0 cites
USD1076063design2025
Infusion Pump
0 cites
USD1070274design2025
Carrying Vest
0 cites
USD1065814design2025
Carrying Pack for Medical Device
0 cites
USD1066015design2025
Container Cap
0 cites
US12172992utility2024
Pyrimidines for Degrading Bruton's Tyrosine Kinase
0 cites
US12157776utility2024
Anti-papp-a Antibodies and Methods of Use Thereof
0 cites
US12157767utility2024
Isolation and Purification of Anti-il-13 Antibodies Using Protein a Affinity Chromatography
0 cites
US12134621utility2024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
0 cites
US12129294utility2024
Methods of Treatment of Diseases in Which IL-13 Activity Is Detrimental Using Anti-il-13 Antibodies
0 cites
US12122826utility2024
Methods of Treatment of Diseases in Which IL-13 Activity Is Detrimental Using Anti-il-13 Antibodies
0 cites
US12116373utility2024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
0 cites
US12110297utility2024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
0 cites
US12110298utility2024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
0 cites
US12103933utility2024
Processes for the Preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and Solid State Forms Thereof
0 cites
US12098189utility2024
Composition and Method for the Diagnosis and Treatment of Iron-related Disorders
0 cites
US12098192utility2024
Composition and Method for the Diagnosis and Treatment of Iron-related Disorders
0 cites

Page 1 of 3Next →